Literature DB >> 32474332

Tetralogy of Fallot palliation in a COVID-19 positive neonate.

Irim Salik1, Bhupen Mehta2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32474332      PMCID: PMC7247454          DOI: 10.1016/j.jclinane.2020.109914

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


× No keyword cloud information.
In December 2019, a novel coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), causing severe pneumonia was identified in patients in Wuhan, China, leading to the syndrome known as Coronavirus Disease 2019 (COVID-19) [1]. Although severe multisystemic manifestations have been defined in adults, there is limited data on the disease burden of COVID-19 in infants. We present the case of a 15-day-old infant who was born with Tetralogy of Fallot (TOF), and was found to be COVID-19 positive. Among symptomatic children, 5% have dyspnea or hypoxemia, and 0.6% progress to acute respiratory distress or multi organ dysfunction [2]. This TOF infants' acute degeneration in clinical presentation and the need for urgent surgical palliation may have been confounded by a positive COVID-19 diagnosis. The patient's family provided informed consent to publish this manuscript. A 15-day-old baby girl, born at 37-weeks, weighing 1.9 kg, was diagnosed with TOF prenatally. The infant's mother was diagnosed with COVID-19 after experiencing fever and shortness of breath postpartum. On day 7 of life, the infant experienced desaturation to SpO2 60–65%, tachypnea, worsening cyanosis, feeding intolerance and increasing lethargy. Chest radiography revealed bilateral pulmonary granular opacities and reduced lung volumes. A COVID nasopharyngeal swab was positive; and the infant exhibited frequent Tet spells requiring supplemental oxygen and recurrent fluid boluses. The infant was intubated due to repeated apneic episodes. Due to sustained hypoxemia with SpO2 between 55 and 65%, the decision for surgical palliation of TOF with a systemic-to-pulmonary shunt was made. The patient arrived to the operating room for Blalock-Taussig (BT) shunt placement on day 15 of life. Weighing 2.3 kg, she was transported to a dedicated operating room, with a Pyxis machine situated outside so as not to contaminate its' contents. A high efficiency particulate air filter was in place distal to the endotracheal tube (ETT) along with a second filter attached to the expiratory limb of the anesthesia circuit. Standard ASA monitors were applied and a left femoral arterial line was placed under ultrasound guidance. The infant arrived intubated with a 3.0 uncuffed ETT; 1 μg/kg fentanyl and 2 mg/kg rocuronium were bolused following arterial line placement. Shortly thereafter, ventilation became challenging and a significant ETT leak was appreciated. Double filters also added to circuit dead space and capnography waveform yielded an end tidal CO2 < 10 mmHg. The uncuffed ETT was replaced with a cuffed ETT to enable more effective ventilation and reduce aerosolization of viral particles. A C-MAC® video laryngoscope was utilized with a Miller 0 blade and the cuff was inflated immediately after direct visualization of appropriate endotracheal placement. An in-line suctioning system was placed to prevent aerosolization during suctioning. Modified BT shunt placement proceeded without complication and the patient was transferred to the ICU intubated in stable condition, on a phenylephrine infusion at 0.2 μg/kg/min. The patient was extubated on postoperative day 6 in stable condition; repeat testing for COVID-19 was negative. Vertical transmission of SARS-CoV-2 is unlikely, as it has not been detected in umbilical cord blood, amniotic fluid, placental tissue, vaginal swabs, or breast milk and maternal viremia rates are 1% in a study by Wang et al. [3] Although elevated immunoglobulin M, cytokine levels, and lymphocyte counts may be suspicious of in utero infection, current data suggests early neonatal infection is most likely due to postnatal contact with caregivers. Only 2 cases of neonates with positive real-time polymerase chain reaction testing after delivery have been described [4], but these cases lack clinical data and information about appropriate isolation precautions. Options for surgical management of TOF include initial palliation with a modified BT shunt, stenting of the right ventricular outflow tract or early primary repair (EPR). The advantages of EPR include quicker resolution of right ventricular hypertrophy, prevention of prolonged cyanosis, reduced myocardial fibrosis and arrhythmias, and improved exercise tolerance [5]. Concern for coagulopathy, delayed sternal closure, and prolonged hospital stay in this infant following a cardiopulmonary bypass run were instrumental in the decision to proceed with a BT shunt as opposed to EPR. In the face of this sustained public health crisis, the concomitant occurrence of SARS-CoV-2 with pediatric congenital heart disease mandates guidance to ensure patient safety.

Declaration of competing interest

The authors declare that there is no conflict of interest.
  11 in total

1.  Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization.

Authors:  Jolanda Sabatino; Giovanni Di Salvo; Giuseppe Calcaterra; Pier Paolo Bassareo; Lilia Oreto; Ilaria Cazzoli; Maria Pia Calabrò; Paolo Guccione; Michael A Gatzoulis
Journal:  Int J Cardiol Congenit Heart Dis       Date:  2021-06-16

2.  Cardiovascular impact of COVID-19 with a focus on children: A systematic review.

Authors:  Moises Rodriguez-Gonzalez; Ana Castellano-Martinez; Helena Maria Cascales-Poyatos; Alvaro Antonio Perez-Reviriego
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

3.  Synthesis and systematic review of reported neonatal SARS-CoV-2 infections.

Authors:  Roberto Raschetti; Alexandre J Vivanti; Christelle Vauloup-Fellous; Barbara Loi; Alexandra Benachi; Daniele De Luca
Journal:  Nat Commun       Date:  2020-10-15       Impact factor: 14.919

Review 4.  Updates in neonatal coronavirus disease 2019: What can we learn from detailed case reports? (Review).

Authors:  Xingchao Li; Li Sun; Tao Li
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

5.  Clinical implications of coronavirus disease 2019 in neonates.

Authors:  Do-Hyun Kim
Journal:  Clin Exp Pediatr       Date:  2021-02-04

6.  SARS-CoV-2 in a Neonate with Truncus Arteriosus: Management and Surgical Correction Timing.

Authors:  M Masci; P Moras; L Di Chiara; L Pasquini; C M Campanale; P Bagolan; L Galletti; A Toscano
Journal:  Pediatr Cardiol       Date:  2021-10-21       Impact factor: 1.655

7.  Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding.

Authors:  Monique A L J Slaats; Maud Versteylen; Karin B Gast; Bas B Oude Munnink; Suzan D Pas; Robbert G Bentvelsen; Ron van Beek
Journal:  J Infect Public Health       Date:  2020-10-27       Impact factor: 3.718

8.  Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review.

Authors:  Elizabeth Centeno-Tablante; Melisa Medina-Rivera; Julia L Finkelstein; Pura Rayco-Solon; Maria Nieves Garcia-Casal; Lisa Rogers; Kate Ghezzi-Kopel; Pratiwi Ridwan; Juan Pablo Peña-Rosas; Saurabh Mehta
Journal:  Ann N Y Acad Sci       Date:  2020-08-28       Impact factor: 5.691

9.  COVID-19 in Neonates with Positive RT-PCR Test. Systematic Review.

Authors:  Heladia García; Aldo Allende-López; Paulina Morales-Ruíz; Guadalupe Miranda-Novales; Miguel Ángel Villasis-Keever
Journal:  Arch Med Res       Date:  2022-03-14       Impact factor: 8.323

Review 10.  Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations.

Authors:  Pedro A Pousa; Tamires S C Mendonça; Eduardo A Oliveira; Ana Cristina Simões-E-Silva
Journal:  J Pediatr (Rio J)       Date:  2020-09-22       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.